Icon (BSP:ICLR34) Short-Term Debt: R$2,770 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:ICLR34 Icon PLC BSP:ICLR34
68 GF Score
Price R$42.48
GF Value R$58.21
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Icon Short-Term Debt?

Icon BSP:ICLR34 +17.84% 68 Short-Term Debt is R$2,770 Mil as of Mar. 2026. GuruFocus rates BSP:ICLR34 with a GF Score™ of 68/100 and a GF Value™ of R$58.21 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Icon's Short-Term Debt for the quarter that ended in Mar. 2026 was R$2,770 Mil.

Icon's quarterly Short-Term Debt increased from Sep. 2025 (R$2,841 Mil) to Dec. 2025 (R$2,890 Mil) but then declined from Dec. 2025 (R$2,890 Mil) to Mar. 2026 (R$2,770 Mil).

Icon's annual Short-Term Debt declined from Dec. 2023 (R$540 Mil) to Dec. 2024 (R$182 Mil) but then increased from Dec. 2024 (R$182 Mil) to Dec. 2025 (R$2,890 Mil).

Icon Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Icon Short-Term Debt Related Terms

Icon Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Icon's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Icon Short-Term Debt Chart

Icon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 311.87 289.28 539.71 181.58 2,890.22

Icon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 171.37 165.05 2,841.11 2,890.22 2,770.44
BSP:ICLR34
68GF Score
Icon PLC BSP:ICLR34
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of R$2,770 Mil mean?
Icon (BSP:ICLR34) has a Short-Term Debt of R$2,770 Mil as of Mar. 2026.
Is Icon's Short-Term Debt too high?
Icon's current Short-Term Debt is R$2,770 Mil. Overall, Icon has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Icon's Short-Term Debt compare to RVTY and MEDP?
Icon's Short-Term Debt of R$2,770 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Diagnostics & Research company?
A good Short-Term Debt depends on the Medical Diagnostics & Research industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Icon's current Short-Term Debt is R$2,770 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Icon stock overvalued right now?
Based on GuruFocus' analysis, Icon (BSP:ICLR34) is currently considered Modestly Undervalued. The stock's GF Value™ is R$58.21, compared to a current price of R$42.48 — trading 27% below its estimated fair value. The current Short-Term Debt is R$2,770 Mil. Icon's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Icon (BSP:ICLR34), the current Short-Term Debt is R$2,770 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Icon (BSP:ICLR34) Overvalued in 2026?

Based on GuruFocus' analysis, Icon stock appears to be undervalued. The current stock price of R$42.48 is trading 27% below its estimated GF Value™ of R$58.21. GuruFocus considers Icon to be Modestly Undervalued.

Key valuation signals for BSP:ICLR34:

  • Short-Term Debt: R$2,770 Mil
  • GF Value™: R$58.21 vs. price of R$42.48 (27% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the BSP:ICLR34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Icon Business Description

Other Exchanges ICLR:USAIJF:Germany
Address South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
68GF Score

Get the complete analysis for BSP:ICLR34

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$42.48
Price
R$58.21
GF Value